首页> 外文期刊>Obesity surgery >Remission of type 2 diabetes mellitus should not be the foremost goal after bariatric surgery
【24h】

Remission of type 2 diabetes mellitus should not be the foremost goal after bariatric surgery

机译:减肥手术后缓解2型糖尿病不应是首要目标

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Remission of type 2 diabetes (T2D) is a desired outcome after bariatric surgery (BS). Even if this goal is not achieved, individuals who do not strictly fulfill remission criteria experience an overall improvement. The aim of this study was to evaluate the metabolic control status in patients considered as diabetes "non-remitters." Methods: A retrospective study of 125 patients (59.2 % women) with preoperative diagnosis of T2D who underwent BS in a single center (2006-2011) was conducted. We collected anthropometric and metabolic parameters before surgery and at 1-year follow-up. T2D remission was defined according to the 2009 consensus statement: glycosylated hemoglobin (HbA1c) 6 %, fasting glucose (FG) 100 mg/dLs, and absence of pharmacologic treatment. We evaluated metabolic status of non-remitters, according to the American Diabetes Association's (ADA) target recommendations: HbA1c 7 %, LDL-c 100 mg/dL, triglycerides 150 mg/dL, and HDL-c 40 (male) or 50 mg/dL (female). Statistics: analysis of variance. Results: Baseline characteristics (mean ± SD): age 53.5 ± 9.7 years, BMI 43.5 ± 5.6 kg/m2, time since diagnosis of T2D 7.7 ± 7.9 years, FG 162.0 ± 56.3 mg/dL, HbA1c 7.7 ± 1.6 %. ADA's target recommendations were present in 12 patients (9.6 %) preoperatively, and in 45 (36.0 %) at 1-year follow-up (p 0.001). Sixty-two (49.6 %) patients did not achieve diabetes remission; 26 (41.9 %) had now diet treatment, 30 (48.4 %) oral medications, and 6 (9.7 %) required insulin. Of the non-remitters, 57 (91.9 %) had HbA1c 7 % and 18 (40.0 %) achieved ADA's target recommendations. There were no differences between remitters and non-remitters in the number of individuals reaching ADA's combined metabolic control. Conclusions: Although almost 50 % of the patients may not be classified as diabetes remitters, their significant improvement in metabolic control should be regarded as a success, according to most scientific societies' target recommendations.
机译:背景:2型糖尿病(T2D)的缓解是减肥手术(BS)之后的理想结果。即使未实现此目标,未严格满足缓解标准的个人也会得到全面改善。这项研究的目的是评估被认为是“非缓解型”糖尿病患者的代谢控制状况。方法:回顾性研究了125例(59.2%的女性)术前诊断为T2D的患者,该患者在单个中心(2006-2011年)接受了BS治疗。我们在手术前和一年的随访中收集了人体测量和代谢参数。根据2009年共识声明定义T2D缓解:糖基化血红蛋白(HbA1c)<6%,空腹血糖(FG)<100 mg / dLs,并且无需药物治疗。根据美国糖尿病协会(ADA)的目标建议,我们评估了非缓解者的代谢状况:HbA1c <7%,LDL-c <100 mg / dL,甘油三酸酯<150 mg / dL,HDL-c> 40(男性)或> 50 mg / dL(女性)。统计:方差分析。结果:基线特征(平均值±标准差):年龄53.5±9.7岁,BMI 43.5±5.6 kg / m2,自诊断为T2D以来的时间7.7±7.9年,FG 162.0±56.3 mg / dL,HbA1c 7.7±1.6%。 ADA的目标推荐存在于术前的12例患者(9.6%)中,以及在1年随访中的45例(36.0%)中(p <0.001)。六十二(49.6%)例患者未实现糖尿病缓解。现在有26名(41.9%)接受了饮食治疗,30种(48.4%)口服药物和6种(9.7%)需要胰岛素。在非缓解者中,HbA1c <7%的患者为57名(91.9%),而ADA的目标推荐率为18%(40.0%)。缓解者与非缓解者之间达到ADA合并代谢控制的个体数量没有差异。结论:尽管将近50%的患者可能没有被归类为糖尿病缓解者,但根据大多数科学协会的目标建议,他们在代谢控制方面的显着改善应被视为成功。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号